These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19635103)

  • 1. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts.
    Borgogna C; Toniutto P; Smirne C; Azzimonti B; Rittà M; Avellini C; Fabris C; Landolfo S; Gariglio M; Pirisi M
    Histopathology; 2009 Jun; 54(7):837-46. PubMed ID: 19635103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
    MacQuillan GC; de Boer WB; Allan JE; Platten MA; Reed WD; Jeffrey GP
    Clin Transplant; 2010; 24(2):252-8. PubMed ID: 19712085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
    Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
    Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection.
    Ghabril M; Dickson RC; Krishna M; Bonatti H; Aranda-Michel J; Keaveny AP; Satyanarayana R; Hewitt W; Hughes CB; Nguyen JH
    Transplantation; 2009 Apr; 87(8):1174-9. PubMed ID: 19384164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F
    Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular damage caused by cellular and humoral immunity in liver allograft rejection.
    Sawada T; Shimizu A; Kubota K; Fuchinoue S; Teraoka S
    Clin Transplant; 2005 Feb; 19(1):110-4. PubMed ID: 15659143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
    Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M
    Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Banff schema for grading liver allograft rejection: utility in clinical practice.
    Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD
    Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C-associated granulomas after liver transplantation: morphologic spectrum and clinical implications.
    Vakiani E; Hunt KK; Mazziotta RM; Emond JC; Brown RS; Lefkowitch JH; Bhagat G
    Am J Clin Pathol; 2007 Jan; 127(1):128-34. PubMed ID: 17145627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.
    Rosen HR; Doherty DG; Madrigal-Estebas L; O'Farrelly C; Golden-Mason L
    Liver Transpl; 2008 Jan; 14(1):31-40. PubMed ID: 18161829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.